201 related articles for article (PubMed ID: 31089250)
1. Selection of a novel DNA aptamer against OFA/iLRP for targeted delivery of doxorubicin to AML cells.
An Y; Hu Y; Li X; Li Z; Duan J; Yang XD
Sci Rep; 2019 May; 9(1):7343. PubMed ID: 31089250
[TBL] [Abstract][Full Text] [Related]
2. Novel HER2 aptamer selectively delivers cytotoxic drug to HER2-positive breast cancer cells in vitro.
Liu Z; Duan JH; Song YM; Ma J; Wang FD; Lu X; Yang XD
J Transl Med; 2012 Jul; 10():148. PubMed ID: 22817844
[TBL] [Abstract][Full Text] [Related]
3. Induction of cytotoxic T-cell responses against the oncofetal antigen-immature laminin receptor for the treatment of hematologic malignancies.
Siegel S; Wagner A; Kabelitz D; Marget M; Coggin J; Barsoum A; Rohrer J; Schmitz N; Zeis M
Blood; 2003 Dec; 102(13):4416-23. PubMed ID: 12869512
[TBL] [Abstract][Full Text] [Related]
4. Targeted Therapy of Colon Cancer by Aptamer-Guided Holliday Junctions Loaded with Doxorubicin.
Yao F; An Y; Li X; Li Z; Duan J; Yang XD
Int J Nanomedicine; 2020; 15():2119-2129. PubMed ID: 32280210
[TBL] [Abstract][Full Text] [Related]
5. Oligonucleotide aptamer-drug conjugates for targeted therapy of acute myeloid leukemia.
Zhao N; Pei SN; Qi J; Zeng Z; Iyer SP; Lin P; Tung CH; Zu Y
Biomaterials; 2015 Oct; 67():42-51. PubMed ID: 26204224
[TBL] [Abstract][Full Text] [Related]
6. Novel MUC1 aptamer selectively delivers cytotoxic agent to cancer cells in vitro.
Hu Y; Duan J; Zhan Q; Wang F; Lu X; Yang XD
PLoS One; 2012; 7(2):e31970. PubMed ID: 22384115
[TBL] [Abstract][Full Text] [Related]
7. 37 kiloDalton oncofetal antigen protein and immature laminin receptor protein are identical, universal T-cell inducing immunogens on primary rodent and human cancers.
Coggin JH; Barsoum AL; Rohrer JW
Anticancer Res; 1999; 19(6C):5535-42. PubMed ID: 10697612
[TBL] [Abstract][Full Text] [Related]
8. Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer resistance.
Liu J; Wei T; Zhao J; Huang Y; Deng H; Kumar A; Wang C; Liang Z; Ma X; Liang XJ
Biomaterials; 2016 Jun; 91():44-56. PubMed ID: 26994877
[TBL] [Abstract][Full Text] [Related]
9. Identification of oncofetal antigen/immature laminin receptor protein epitopes that activate BALB/c mouse OFA/iLRP-specific effector and regulatory T cell clones.
Rohrer JW; Barsoum AL; Coggin JH
J Immunol; 2006 Mar; 176(5):2844-56. PubMed ID: 16493041
[TBL] [Abstract][Full Text] [Related]
10. PrP
Go G; Lee CS; Yoon YM; Lim JH; Kim TH; Lee SH
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671292
[TBL] [Abstract][Full Text] [Related]
11. Selection of a novel CD19 aptamer for targeted delivery of doxorubicin to lymphoma cells.
Hu Y; Li X; An Y; Duan J; Yang XD
Oncotarget; 2018 Jun; 9(42):26605-26615. PubMed ID: 29928472
[TBL] [Abstract][Full Text] [Related]
12. Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells.
Huang YF; Shangguan D; Liu H; Phillips JA; Zhang X; Chen Y; Tan W
Chembiochem; 2009 Mar; 10(5):862-8. PubMed ID: 19253922
[TBL] [Abstract][Full Text] [Related]
13. Production, safety and antitumor efficacy of recombinant Oncofetal Antigen/immature laminin receptor protein.
Barsoum AL; Liu B; Rohrer JW; Coggin JH; Tucker JA; Pannell LK; Schwarzenberger PO
Biomaterials; 2009 Jun; 30(17):3091-9. PubMed ID: 19268360
[TBL] [Abstract][Full Text] [Related]
14. Aptamer-functionalized albumin-based nanoparticles for targeted drug delivery.
Xu L; He XY; Liu BY; Xu C; Ai SL; Zhuo RX; Cheng SX
Colloids Surf B Biointerfaces; 2018 Nov; 171():24-30. PubMed ID: 30005287
[TBL] [Abstract][Full Text] [Related]
15. Aptamer-guided DNA tetrahedron as a novel targeted drug delivery system for MUC1-expressing breast cancer cells in vitro.
Dai B; Hu Y; Duan J; Yang XD
Oncotarget; 2016 Jun; 7(25):38257-38269. PubMed ID: 27203221
[TBL] [Abstract][Full Text] [Related]
16. Combination of Doxorubicin with Gemcitabine-Incorporated G-Quadruplex Aptamer Showed Synergistic and Selective Anticancer Effect in Breast Cancer Cells.
Joshi M; Choi JS; Park JW; Doh KO
J Microbiol Biotechnol; 2019 Nov; 29(11):1799-1805. PubMed ID: 31546295
[TBL] [Abstract][Full Text] [Related]
17. Synergistic Treatment of Tumor by Targeted Biotherapy and Chemotherapy via Site-Specific Anchoring of Aptamers on DNA Nanotubes.
Chen R; Sun P; Chu X; Pu X; Yang Y; Zhang N; Zhao Y
Int J Nanomedicine; 2020; 15():1309-1320. PubMed ID: 32161460
[TBL] [Abstract][Full Text] [Related]
18. Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles.
Saravanakumar K; Hu X; Shanmugam S; Chelliah R; Sekar P; Oh DH; Vijayakumar S; Kathiresan K; Wang MH
Arch Biochem Biophys; 2019 Aug; 671():143-151. PubMed ID: 31283911
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies specific for oncofetal antigen--immature laminin receptor protein: Effects on tumor growth and spread in two murine models.
McClintock SD; Warner RL; Ali S; Chekuri A; Dame MK; Attili D; Knibbs RK; Aslam MN; Sinkule J; Morgan AC; Barsoum A; Smith LB; Beer DG; Johnson KJ; Varani J
Cancer Biol Ther; 2015; 16(5):724-32. PubMed ID: 25799942
[TBL] [Abstract][Full Text] [Related]
20. A polyvalent aptamer system for targeted drug delivery.
Zhang Z; Ali MM; Eckert MA; Kang DK; Chen YY; Sender LS; Fruman DA; Zhao W
Biomaterials; 2013 Dec; 34(37):9728-35. PubMed ID: 24044994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
